Dr. Michael Stephen Chevinsky, MD

Dr. Chevinsky practices at Metropolitan Urological Specialists, PC in Bethpage, New York.

Dr. Chevinsky's NPI, 1205217122, was assigned on June 16, 2015. Dr. Chevinsky graduated from Rutgers Robert Wood Johnson Medical School in 2015. Dr. Chevinsky holds New York license 326010.

Dr. Chevinsky's primary practice is Metropolitan Urological Specialists, PC, at 480 Hicksville Rd, Bethpage, NY 11714 in Nassau County. The practice phone is (646) 742-8813.

Dr. Chevinsky's primary practice is Metropolitan Urological Specialists, PC in Bethpage, New York. Dr. Chevinsky is also affiliated with St. Joseph Hospital. The medical group on file is Integrated Medical Professionals. Dmand AI also links Dr. Chevinsky to 1 more group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chevinsky practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Chevinsky's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Chevinsky is board certified in urology by the American Board of Urology. Dmand AI has Dr. Chevinsky's licenses on file in 3 states: New York, California and Missouri.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, kidney stone disease, prostate inflammation or infection and prostate surgery among the conditions Dr. Chevinsky treats.

CMS data shows 5,573 Medicare services from Dr. Chevinsky across 32 procedure codes in 2024, for 687 Medicare patients. Medicare paid $247,526 for them.

CMS counts 687 Medicare patients who saw Dr. Chevinsky in 2024. The largest group is 75 to 84, with 253 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chevinsky's median patient age at 68, with 19% women.

In 2024, Dr. Chevinsky wrote 1,711 Medicare Part D claims for 620 patients. 86% of them were for generic drugs. CMS names the drug for 1,577 of them, across 25 drugs with 11 or more claims each, at $230,485 in total drug cost. In 2023, CMS named 1,394 claims across 26 drugs.

Dr. Chevinsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chevinsky as offering telehealth. CMS counts 12 procedures of prostate resection by Dr. Chevinsky, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Chevinsky, published from 2014 to 2021. 2016 was the busiest year, with 8. The most frequent topics are Kidney Neoplasms, Carcinoma, Renal Cell and Nephrectomy. Dr. Chevinsky has published most often in Urology. Dr. Chevinsky's most frequent co-authors are Abraham Ari Hakimi, MD, Paul Russo, MD and Jonathan Andrew Coleman, MD.

CMS Open Payments shows 326 general payments to Dr. Chevinsky from 53 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Astellas Pharma US Inc paid the most, $1,227.

Dr. Chevinsky graduated from Rutgers Robert Wood Johnson Medical School in 2015. Dr. Chevinsky is a member of AUA.

Dr. Chevinsky is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.